SCHEMBL353498

SCHEMBL353498

[O]S(=O)(=O)CCCC(F)(F)F

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1767019 0.92 TXNRD1 (0.32) ESR1ESR2
SCHEMBL4200390 0.82 CA1 (0.31)
SCHEMBL14814813 0.81 ALDH1A1 (0.35)
SCHEMBL309951 0.80 CES1 (0.33)
SCHEMBL6148010 0.76 CA1 (0.37)
SCHEMBL14814810 0.76
SCHEMBL3097818 0.76
SCHEMBL216634 0.76 APP (0.46) ESR1ESR2
SCHEMBL6054656 0.74
SCHEMBL19811360 0.74 GMNN (0.48) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910331-A1 PYRAZOLE DERIVATIVES AS CBl MODULATORS AstraZeneca AB (SE) 2008-04-16 EP claimed
WO-2007010217-A1 PYRAZOLE DERIVATIVES AS CBl MODULATORS ASTRAZENECA AB (SE) 2007-01-25 WO claimed
CN-105732296-B 7-methyl-3-methyl-7-octenyl halide, preparation method thereof and method for preparing 7-methyl-3-methyl-7-octenyl propionate 信越化学工业株式会社 2023-05-02 CN disclosed
US-9963451-B2 Fused ring pyrimidine compound and pest control agent containing the same MITSUI CHEMICALS AGRO, INC. (JP) 2018-05-08 US disclosed
WO-2017070003-A1 USE OF PRODRUGS OF 1,3-PROPANEDISULFONIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR THE TREATMENT OF SARCOIDOSIS KIACTA SÁRL (CH) 2017-04-27 WO disclosed
US-9481619-B2 7-methyl-3-methylene-7-octenyl halide, method for producing the same, and method for producing 7-methyl-3-methylene-7-octenyl propionate SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-11-01 US disclosed
EP-1836161-B1 METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES BHI LTD PARTNERSHIP (CA) 2016-07-20 EP disclosed
US-20160185690-A1 7-METHYL-3-METHYLENE-7-OCTENYL HALIDE, METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING 7-METHYL-3-METHYLENE-7-OCTENYL PROPIONATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-06-30 US disclosed
EP-3037403-A1 7-METHYL-3-METHYLENE-7-OCTENYL HALIDE, METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING 7-METHYL-3-METHYLENE-7-OCTENYL PROPIONATE Shin-Etsu Chemical Co., Ltd. (JP) 2016-06-29 EP disclosed
US-20150368249-A1 FUSED RING PYRIMIDINE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) 2015-12-24 US disclosed
US-20140329746-A1 METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2014-11-06 US disclosed
US-20040010009-A1 Benzamidine derivatives SANKYO COMPANY, LIMITED (JP) 2004-01-15 US disclosed
US-6555556-B1 N-(4-(1-acetimidoylpiperidin-4-yl)oxyphenyl)-N-((E)-3-(3 -amidinophenyl)-2-methyl-2-propenyl)sulfamoylacetic acid dihydrochloride for example; factor Xa inhibitors SANKYO COMPANY, LIMITED (JP) 2003-04-29 US disclosed
EP-1245564-A1 BENZAMIDINE DERIVATIVES Sankyo Company, Limited (JP) 2002-10-02 EP disclosed
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed
EP-0486937-B1 Hydrazone derivatives, processes for production thereof, and uses thereof NIHON NOHYAKU CO LTD (JP) 1995-03-22 EP disclosed
US-5358965-A Agricultural and horticultural insecticides, activity against moths and beetles NIHON NOHYAKU CO., LTD. (JP) 1994-10-25 US disclosed
US-5304573-A Insecticides NIHON NOHYAKU CO., LTD. (JP) 1994-04-19 US disclosed
EP-0486937-A1 Hydrazone derivatives, processes for production thereof, and uses thereof NIHON NOHYAKU CO., LTD. (JP) 1992-05-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329746-A1 METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES APP, PSEN1, PSEN2 ESR1 4785/4885ESR2 3845/4885
US-20150368249-A1 FUSED RING PYRIMIDINE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME CBR3, HRH2, HRH4 ESR1 3785/4885ESR2 4109/4885
US-20040010009-A1 Benzamidine derivatives HABP2, F7, F2 ESR1 4592/4885ESR2 3879/4885
US-20160185690-A1 7-METHYL-3-METHYLENE-7-OCTENYL HALIDE, METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING 7-METHYL-3-METHYLENE-7-OCTENYL PROPIONATE CYP3A7, CYP2A7, HSD17B12 ESR1 4335/4885ESR2 3009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.